Our strong operating performance, combined with our reduction in interest expense of more than $32 million resulted in adjusted EPS of $0.23 per share, up $0.14 from Q4 of 2020. As a reminder, the interest expense reduction resulted from the repricing of our term loan and planned paydown of debt consistent with our capital deployment strategy. Now let's take a closer look at the segment performances. In Q4, Sterigenics delivered more than 11% revenue growth and almost 13% segment income growth over Q4 of last year.